Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasm.
Journal: Expert opinion on biological therapy
Published: December 25, 2025
Retrospective analysis of treatment patterns and outcomes in older adults with diffuse large B-cell lymphoma in the Veterans Health Administration.
Journal: Journal of geriatric oncology
Published: February 03, 2025
The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 07, 2023
Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study.
Journal: Current oncology (Toronto, Ont.)
Published: August 22, 2023
Clinical Characteristics, Treatment Patterns, and Outcomes of Patients With Locally Advanced/Metastatic Hepatocellular Carcinoma Treated at the Veterans Health Administration.
Journal: The oncologist
Published: August 12, 2023
Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the veteran's healthcare administration.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: June 13, 2023
Health disparity in use of novel agents for first-line therapy in Black and White patients with chronic lymphocytic leukemia in the Department of Veterans Affairs.
Journal: Journal of managed care & specialty pharmacy
Published: March 29, 2023
Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration.
Journal: The oncologist
Published: January 09, 2023
Last Updated: 09/26/2026